Bioavailability estimation by semisimultaneous drug administration: A Monte Carlo simulation study
暂无分享,去创建一个
[1] Yasuaki Ogawa,et al. Estimation of drug absorption rates using a deconvolution method with nonequal sampling times , 1986, Journal of Pharmacokinetics and Biopharmaceutics.
[2] P. Collier,et al. Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant , 1983, Journal of Pharmacokinetics and Biopharmaceutics.
[3] L. Benet,et al. An integrated approach to the pharmacokinetic analysis of drug absorption , 1974, Journal of pharmacokinetics and biopharmaceutics.
[4] U. Bredberg,et al. Estimation of Bioavailability on a Single Occasion After Semisimultaneous Drug Administration , 1989, Pharmaceutical Research.
[5] A. Grahnén,et al. Implications of intraindividual variability in bioavailability studies of furosemide , 2004, European Journal of Clinical Pharmacology.
[6] Weiner Dl. NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models. , 1986 .
[7] R. Wolen. The Application of Stable Isotopes to Studies of Drug Bioavailability and Bioequivalence , 1986, Journal of clinical pharmacology.
[8] M. Gibaldi,et al. Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vivo dissolution rates. , 1985, Journal of pharmaceutical sciences.
[9] J. Wagner,et al. The Assessment of the Intrasubject Variability in Digoxin Absorption in Man from Two Oral Dosage Forms , 1981, Journal of clinical pharmacology.
[10] S. Szefler,et al. Intrasubject variation in sustained-release theophylline absorption. , 1981, The Journal of allergy and clinical immunology.
[11] F. Koss,et al. The use of stable isotopes to prove the saturable first-pass effect of methoxsalen. , 1980, Biomedical mass spectrometry.
[12] K. C. Kwan,et al. Bioavailability assessment under quasi- and nonsteady-state conditions III: Application. , 1976, Journal of Pharmacy and Science.
[13] K. C. Kwan,et al. Bioavailability assessment under quasi- and nonsteady-state conditions II: study designs. , 1976, Journal of Pharmacy and Science.
[14] E. E. Mitchell,et al. Advanced Continuous Simulation Language (ACSL) , 1976 .
[15] A. Atkinson,et al. Absolute bioavailability in man of N‐acetylprocainamide determined by a novel stable isotope method , 1975, Clinical pharmacology and therapeutics.
[16] K. C. Kwan,et al. Bioavailability assessment under quasi- and nonsteady-state conditions. I: theoretical considerations. , 1975, Journal of Pharmacy and Science.
[17] K. C. Kwan,et al. Novel method for bioavailability assessment. , 1973, Journal of pharmaceutical sciences.